376-390 of 905
Behind the Scenes of the Johns Hopkins Coronavirus Tracking Map
Public Health On CallBehind the Scenes of the Johns Hopkins Coronavirus Tracking Map
Joshua Sharfstein, MD
Beth Blauer
Cardio-Oncology Perspectives on COVID-19 from the Mayo Clinic
COVID-19: On The FrontlinesCardio-Oncology Perspectives on COVID-19 from the Mayo Clinic
Matt Birnholz, MD
Kathryn J. Ruddy, MD
Joerg Herrmann, MD
Off-Label Medicines in Fighting COVID-19 & Through the Years
COVID-19: On The FrontlinesOff-Label Medicines in Fighting COVID-19 & Through the Years
John Russell, MD
John Russell, MD
John Russell, MD
HHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities
The Drug ReportHHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities
Linda Bernstein, Pharm.D.
- advertisement
Drug Shortages During the COVID-19 Pandemic
The Drug ReportDrug Shortages During the COVID-19 Pandemic
Linda Bernstein, Pharm.D.
Novel Therapeutic & Prevention Approaches to the Novel Coronavirus
The Drug ReportNovel Therapeutic & Prevention Approaches to the Novel Coronavirus
Linda Bernstein, Pharm.D.
Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
The Drug ReportUncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
Linda Bernstein, Pharm.D.
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
The Drug ReportA Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
Linda Bernstein, Pharm.D.
REMS-Required Drug Monitoring During the COVID-19 Pandemic
The Drug ReportREMS-Required Drug Monitoring During the COVID-19 Pandemic
Linda Bernstein, Pharm.D.
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
The Drug ReportRenin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
Linda Bernstein, Pharm.D.
- advertisement
CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
The Drug ReportCDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
Linda Bernstein, Pharm.D.
Joshua Sharfstein, MD
Paul B. Spiegel, MD
John Barry
Amesh Adalja, Infectious Disease Expert, Answers Your Latest COVID-19 Questions
Public Health On CallAmesh Adalja, Infectious Disease Expert, Answers Your Latest COVID-19 Questions
Joshua Sharfstein, MD
Amesh Adalja, MD, FIDSA
